Clinical Trials Logo

Perinatal HIV Infection clinical trials

View clinical trials related to Perinatal HIV Infection.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT05328713 Completed - Cardiac Fibrosis Clinical Trials

Immune Correlates of Cardiac Structure and Function

Start date: May 9, 2022
Phase:
Study type: Observational

The purpose of this study is to determine the occurrence of scarring of the heart (cardiac fibrosis) and inflammation in those with perinatally acquired Human Immunodeficiency Virus (HIV) infection compared to people not infected with HIV. The information learned from this research may help the investigator to better understand the link between cardiac fibrosis and cardiac dysfunction and inflammation in those with perinatally acquired HIV infection compared to the uninfected. Participants will have a blood sample, complete a patient questionnaire, and have a Magnetic resonance imaging (MRI) and ultrasound of the heart. Researchers will review the medical record and past medical history, for information about your heart function and overall health. Research samples and data from this study will be stored indefinitely and used for other research. There are risks to participate in this study and those risks include side effects from the contrast agent used for the MRI scan, (such as headache and injection site pain), and risks from blood sampling.

NCT ID: NCT05206123 Completed - Hiv Clinical Trials

Sexual Needs of Adolescents Living With HIV Since Childhood

SSVIH
Start date: March 17, 2022
Phase:
Study type: Observational

To improve the knowdelge about the sexual health needs of perinatally HIV-infected adolescents living in France.

NCT ID: NCT04206241 Completed - HIV Infections Clinical Trials

Assessing the Feasibility, Acceptability and Effects Of HIV Birth Testing In Maternity Settings In Zimbabwe

Start date: January 1, 2018
Phase:
Study type: Observational

This study aims to assess the feasibility and, acceptability and effects of implementing HIV testing at birth testing using point-of-care (POC) HIV nucleic acid testing (NAT) in maternity settings.